FSMAX
Price
$101.54
Change
-$1.22 (-1.19%)
Updated
Oct 7 closing price
Net Assets
41.44B
IBSSX
Price
$16.90
Change
-$0.17 (-1.00%)
Updated
Oct 7 closing price
Net Assets
325.93M
Interact to see
Advertisement

FSMAX vs IBSSX

Header iconFSMAX vs IBSSX Comparison
Open Charts FSMAX vs IBSSXBanner chart's image
Fidelity Extended Market Index
Price$101.54
Change-$1.22 (-1.19%)
VolumeN/A
Net Assets41.44B
VY® Baron Growth S
Price$16.90
Change-$0.17 (-1.00%)
VolumeN/A
Net Assets325.93M
FSMAX vs IBSSX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. IBSSX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and IBSSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.4B vs. IBSSX (326M). FSMAX pays higher dividends than IBSSX: FSMAX (0.44) vs IBSSX (0.28). FSMAX was incepted earlier than IBSSX: FSMAX (14 years) vs IBSSX (23 years). IBSSX (1.37) is less costly to investors than FSMAX (0.04). FSMAX is a more actively managed with annual turnover of: 9.00 vs. IBSSX (4.00). FSMAX (0) and IBSSX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 19.58 vs. IBSSX (-27.56). FSMAX return over 5 years is better than : 53.17 vs. IBSSX (-30.42).
FSMAXIBSSXFSMAX / IBSSX
Total Expense Ratio0.041.253%
Annual Report Gross Expense Ratio0.041.373%
Fund Existence14 years23 years-
Gain YTD13.072-27.284-48%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets41.4B326M12,699%
Annual Yield % from dividends0.440.28155%
Returns for 1 year19.58-27.56-71%
Returns for 3 years70.02-15.68-447%
Returns for 5 years53.17-30.42-175%
Returns for 10 years107.23-38.88-276%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLIDX15.65N/A
N/A
Harding Loevner Intl Dev Mkts Eq Inst
FPHAX28.62N/A
N/A
Fidelity Select Pharmaceuticals Port
UTMAX12.03N/A
N/A
Victory Target Managed Allocation
GSILX21.81N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps C
DLCZX12.27-0.06
-0.49%
Destinations Large Cap Equity Z